BIT's 8th New Energy Forum & 1st World Congress of Energy Storage-2019 (WCES-2019)
Welcome

BIT's 1st World Congress of Energy Storage-2019 (WCES-2019), with the theme of “Dedicated to Building Global Green Energy Ecosystem” will be held during June 28-30, 2019 at Dalian, China.


This unique international conference creates a great platform to researches, scientists, academicians and industry experts to share experiences, discuss research findings and acquire the desired knowledge for practical exercise. WCES-2019 is a dedicated event where you will have the opportunity to learn about new developments in the field of energy storage and its application at clean energy area, and share aspects of your own work. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better practice and application. We hope your participation would contribute to your professional development and relationships. 


Wish you enjoy the conference!

Program at a Glance

Theme 1
Glory Hall
-Pre-conference Activities

Theme 2
Brain Nation Theatre
-Innovative Nation Summit

Theme 3
Master Rostrum
-Great Mind Forums

Theme 4
Disruptive Universe
-Frontier of Hard Sci-Tech

Theme 5
Convergence Station
-Tech Convergence and Cases Study

Theme 6
Hacker Village
-Futuristic Tech

Theme 7
Roundtable
-Meeting Decision Maker

Theme 8
Showtime Square
-Leading Hot Tech Expo

Theme 9
Matchmaking Corner
-Business Development

Theme 10
Joyful Commune
-Social/Cultural Events


Sir Richard Timothy Hunt, FRS FMedSci FRSE (born 19 February 1943) is a British biochemist and molecular physiologist. He was awarded the 2001 Nobel Prize in Physiology or Medicine with Paul Nurse and Leland H. Hartwell for their discoveries of protein molecules that control the division of cells. In particular, Hunt discovered what he called cyclin: a protein in fertilised sea urchin eggs which cyclically aggregates and is depleted during cell division cycles. Following his PhD, Hunt returned to New York to work with London, in collaboration with Nechama Kosower, her husband Edward Kosower, and Ellie Ehrenfeld. While there, they discovered that tiny amounts of glutathione inhibited protein synthesis in reticulocytes and that tiny amounts of RNA killed the synthesis altogether. After returning to Cambridge, he again began work with Tony Hunter and Richard Jackson, who had discovered the RNA strand used to start haemoglobin synthesis. After 3–4 years, the team discovered at least two other chemicals acting as inhibitors.Hunt was elected a member of the European Molecular Biology Organization (EMBO) in 1978, serving as a member of the organisation's Fellowship Committee 1990–1993, its Meeting Committee 2008–2009, and its governing body, the Council, 2004–2009. He was elected a Fellow of the Royal Society (FRS) in 1991.


Behzad Mahdavi is serving as Vice President of Strategic Innovation & Alliances at Lonza, one of the world's leading suppliers to the Pharma&Biotech and Specialty Ingredient markets, as a Chairman of the Board of Exosomics, an innovator leader in the field of Liquid Biospy and as a member of Investment and Advisory committee for C3E Venture Capital Fund, one of the most active private fund in Canada. He began in his current position at Lonza in 2010 after three years serving as Head of Lonza Canada. Prior to joining Lonza, he was CEO of SAM Electron Technologies, a venture capital-backed company in the Life Sciences field, which was acquired in 2007 by a multinational company. During his entire career, Behzad worked for several private organizations, governmental companies and venture capital firms in different capacities as senior executive, advisor, CEO and board member.  In these roles, he was involved in leading, managing and advising technological start-ups/companies in fund raising, strategic business development, efficient innovation management and commercialization/spinoff to create new profitable growth axis. He earned his MBA from the University of Quebec in Montreal, Canada, his Ph.D. in Chemistry from University of Sherbrooke, Canada, his M.S. in Industrial Chemicals & Environment from the University of Rennes, France and his B.Sc. in Chemical Engineering from ENSCR, France.


Dr. Reiko Kuroda, Professor at Research Institute for Science and Technology at Tokyo University of Science/ Professor Emeritus at The University of Tokyo, has obtained Ph.D. in Chemistry from The University of Tokyo. She worked at King’s College London in the Department of Chemistry and then Biophysics, as well as at Institute of Cancer Research, UK. Returned to Japan as an Associate Professor, and became a full professor in 1992, the first female full professor in the field of natural sciences at the University of Tokyo. She is a chemist as well as biologist and her main research interest is chiromorphology. In addition to her scientific activity, she is involved in science policy, higher education policy, science communication and promotion of STEM career especially for women/girls. L’Oreal UNESCO Women in Science Award (2013), Vice president of ICSU (International Council for Science, 2008-11), Scientific Advisory Board to the UN Secretary General (2013-16) etc.In Japan, member of Council of Science and Technology Policy (2001-7), and Ambassador of WINDS (Women’s Initiative in Developing STEM Career) (2016- ). She is a member of the Royal Swedish Academy of Sciences.


Professor Kazuhide Inoue is the Executive Vice-President of Kyushu University. ProfessorInoue has published over 200 papers on the subject of the function of purinergic receptors in CNS, especially in pain signaling. Inoue’s group has found that P2X4 receptors in spinal microglia has important role in the expression of neuropathic pain that is often refractory to treatment with NSAIDs and opioids, and the stimulation of P2Y6 receptors causes microglial phagocytosis.In 1975, he graduated School of Pharmaceutical Sciences, Kyushu University, and 1978 he started to research at National Institute of Health Sciences, Japan. After obtaining Ph.D from Kyusyu University in 1985, he studied abroad in NIH, USA, as a visiting fellow until 1987. He again studied abroad in University College London (Prof. G Burnstock), as an honorary research fellow from 1991 till 1992. In 2000, he became a professor of Graduate School of Pharmaceutical Sciences, Kyushu University. From 2014 till now, he works asthe Executive Vice-President of Kyushu University. He was awarded Science Technology Award from the Minister of Education, Culture, Sports, Science and Technology-Japan in 2007, the 3rd SetsuroEbashi Prize of The Japanese Pharmacological Society in 2010, Medal from His Majesty the Spanish Emperor as an honor of Royal Academy of Pharmacy in 2010, The Pharmaceutical Society of Japan Award in 2013, and Medal with Purple Ribbon from His Majesty the Emperor in 2014.


James Shen is a molecular geneticist working on gene regulation. He has a BS degree from the Dept. of Chemistry, National Taiwan University and a PhD degree from the Chemistry Dept. of the University of California, Berkeley. He received his postdoctoral training at Cal Tech and was a faculty at the University of California, Davis from 1981-1999. From 1995-2004, he was the Director of the Institute of Molecular Biology (IMB), Academia Sinica, Taipei, Taiwan. He is now a Distinguished Research Fellow at IMB. His research interests cover the molecular and cellular basis of hematopoietic gene regulation, neuronal plasticity, development, and cell differentiation in relation to chromatin structure and epigenetics. He is an Academician of the Academia Sinica, an elected Fellow of the American Association for the Advancement of Science (AAAS), and an elected Fellow of the Third World Academy of Sciences.


Dr. William G. Rice serves as Chairman, President and CEO of Aptose Biosciences Inc., a publicly traded clinical stage biotechnology company developing first-in-class targeted agents to treat life-threatening hematological malignancies. Prior to Aptose, Dr. Rice served as Chairman, President, CEO of Cylene Pharmaceuticals, Inc. and led the development and sale of small molecule therapeuticsthat exploit kinase pathways and non-genotoxic mechanisms for activating p53 to kill cancer cells. Before Cylene, Dr. Rice was Founder, President, CEO and Director of Achillion Pharmaceuticals, Inc. Prior to that, he served as Senior Scientist and Head of the Drug Mechanism Laboratory at the National Cancer Institute-Frederick Cancer Research and Development Centerand a Visiting Scientist to the IMCB of Singapore, and as a professorof Pediatric Hematology and Oncology at Emory University School of Medicine. Dr.Rice has held leadership roles in industry, government and academic sectors and accrued more than 30 years of executive, operational, business development, financial, product research, and product development skills.Over the course of his career, Dr. Rice identified multiple new molecular drug targets, delivered multiple first-in-class drugs to the clinic, and published peer-reviewed findings in Science, Nature, Cell, Nature Medicine, Proceedings of the National Academy of Sciences, among other prestigious journals. Dr. Rice holds a Ph.D. in Biochemistry from Emory University and was a postdoctoral trainee in the Department of Internal Medicine at the University of Michigan Medical Center.

Renowned Speakers of Previous Conference

Dr. Dennis Bracy
CEO
US-China Clean Energy Forum
USA

Dr. Maher Chebbo
President
European Smart Energy Association (ESMIG)
Germany

Dr. Hossam Gabbar
Professor
University of Ontario Institute of Technology
Canada

Dr. Sergio C. Trindade
President
SE2T International, Ltd
USA

Mr. Joel Cherry
President 
Research & Development 
Amyris
USA

Mr. Andrew Lang
Vice President
World Bioenergy Association Australia

Dr. Goon Cherl Park
Former President
KINGS University
South Korea

Dr. Hans van Ginkel
Former Under-Secretary General
United Nations
The Netherlands

Dr. Subhash Singhal
Battelle Fellow
Pacific Northwest National Laboratory
USA

Dr. John H. Patterson
President
Mr Sun Solar
USA

Dr. Elio Santacesaria
Professor
Eurochem Engineering LtD
Italy

Dr. Francois Nguyen
International Energy Policy Expert
Alberta
Canada

Dr. Tatsuhiko Fujihira
Chief Technology Officer for Electronic Devices
Fuji Electric Co., Ltd.
Japan

Dr. Wolfram Sparber
Head of Institute Renewable Energy
EURAC Research
Italy

Mr. Giorgio Fortunato
Head of Marketing and Communications
Vestas Wind Systems
China

Mr. Mathias Steck
Senior Vice President & Regional Manager Asia Pacific
GL Garrad Hassan
China

Dr. Paul Alexander Harten
Managing Director
LIMO Lissotschenko Mikrooptik GmbH
Germany

Mr. Michael Gorton
CEO
Principal Solar, Inc.
USA

Dr. Ted Guo
Vice President
ENN Solar Energy Co, Ltd.
China

Mr. Arturo Herrero
Chief Strategy Officer & Head of Emerging Markets
Jinko Solar Co., Ltd.
China

Previous Event Report
Exhibition and Sponsorship

WCES-2019 provides an ideal platform to showcase your new technologies and products in China. And it is developed to maximize your exposure, generate new leads, build brand awareness, and solidify business relations. Our conference provides your company with an unparalleled marketing opportunity to get before industry decision-makers. Exhibiting at the right exhibition can be one of the most efficient, effective and successful marketing activities available to you. More>>

WCES-2019 is one of the most effective international marketing platforms in the field of energy storage and clean energy, which offers a wide range of sponsoring categories for branding and highlighting your company in order to achieve the best publicity.More>>

Scenery of Dalian

Dalian — the "Northern Pearl" and summer resort of China, compared to ancient capital cities such as Beijing, Xian, Nanjing or Luoyang, is a young city with only a 100-year history. Situated at the tip of China's Liaodong Peninsular, it is a trading and financial center in northeastern Asia and has gained the name the 'Hong Kong of Northern China'. It is one of the most popular tourist spots in China, offering an intriguing blend of modern and traditional Chinese culture.

News Released

Conference Venue Released
Speaking proposals are now being accepted, submit the abstract right now!
Welcome your participation as Session Chair/Session Speaker
Call for Exhibitors and Sponsors
Call for Collaborative Partners, Media and Journals

Hosting Organization

说明: C:\Users\Administrator\AppData\Roaming\feiq\RichOle\1247034230.bmp
Information Research Center of International Talent, China State Administration of Foreign Experts Affairs, China

Supporting Organization

说明: C:\Users\Administrator\AppData\Roaming\feiq\RichOle\2375059670.bmp
China Council for the Promotion of Intemational Trade, Dalian Sub-Council

Operating Organization
Official Travel Agency
BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2017-2018 BIT Congress Inc.